Despite mounting concerns about heart risks from the diabetes pill, the Food and Drug Administration has decided it can stay on the market. European regulators determined the risks outweigh the benefits and will pull the drug.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/09/23/130072826/fda-keeps-avandia-on-market-europeans-pull-drug?ft=1&f=103537970
Posted
Sep 23 2010, 09:41 AM
by
NPR Blogs: Shots - Health News Blog